These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 7685191)
41. Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse). Baumgart E; Vanhorebeek I; Grabenbauer M; Borgers M; Declercq PE; Fahimi HD; Baes M Am J Pathol; 2001 Oct; 159(4):1477-94. PubMed ID: 11583975 [TBL] [Abstract][Full Text] [Related]
42. Clinical recognition of patients affected by a peroxisomal disorder: a retrospective study in 40 patients. Theil AC; Schutgens RB; Wanders RJ; Heymans HS Eur J Pediatr; 1992 Feb; 151(2):117-20. PubMed ID: 1371465 [TBL] [Abstract][Full Text] [Related]
47. Plasma bile acids in patients with peroxisomal dysfunction syndromes: analysis by capillary gas chromatography-mass spectrometry. Clayton PT; Lake BD; Hall NA; Shortland DB; Carruthers RA; Lawson AM Eur J Pediatr; 1987 Mar; 146(2):166-73. PubMed ID: 2436918 [TBL] [Abstract][Full Text] [Related]
48. In situ genetic complementation analysis of cells with generalized peroxisomal dysfunction. Singh AK; Kulvatunyou N; Singh I; Stanley WS Hum Hered; 1989; 39(5):298-301. PubMed ID: 2482247 [TBL] [Abstract][Full Text] [Related]
49. Genetic heterogeneity in the cerebrohepatorenal (Zellweger) syndrome and other inherited disorders with a generalized impairment of peroxisomal functions. A study using complementation analysis. Brul S; Westerveld A; Strijland A; Wanders RJ; Schram AW; Heymans HS; Schutgens RB; van den Bosch H; Tager JM J Clin Invest; 1988 Jun; 81(6):1710-5. PubMed ID: 2454948 [TBL] [Abstract][Full Text] [Related]
50. [Peroxisomal neurologic diseases and Refsum disease: very long chain fatty acids and phytanic acid as diagnostic markers]. Molzer B; Stöckler S; Bernheimer H Wien Klin Wochenschr; 1992; 104(21):665-70. PubMed ID: 1282286 [TBL] [Abstract][Full Text] [Related]
51. Clinical approach to inherited peroxisomal disorders: a series of 27 patients. Baumgartner MR; Poll-The BT; Verhoeven NM; Jakobs C; Espeel M; Roels F; Rabier D; Levade T; Rolland MO; Martinez M; Wanders RJ; Saudubray JM Ann Neurol; 1998 Nov; 44(5):720-30. PubMed ID: 9818927 [TBL] [Abstract][Full Text] [Related]
52. Peroxisomal localization in the developing mouse cerebellum: implications for neuronal abnormalities related to deficiencies in peroxisomes. Nagase T; Shimozawa N; Takemoto Y; Suzuki Y; Komori M; Kondo N Biochim Biophys Acta; 2004 Mar; 1671(1-3):26-33. PubMed ID: 15026142 [TBL] [Abstract][Full Text] [Related]
53. Abnormal profiles of polyunsaturated fatty acids in the brain, liver, kidney and retina of patients with peroxisomal disorders. Martinez M Brain Res; 1992 Jun; 583(1-2):171-82. PubMed ID: 1504825 [TBL] [Abstract][Full Text] [Related]
54. Dihydroxyacetone phosphate acyltransferase and alkyldihydroxyacetone phosphate synthase activities in rat liver subcellular fractions and human skin fibroblasts. Singh H; Usher S; Poulos A Arch Biochem Biophys; 1989 Feb; 268(2):676-86. PubMed ID: 2464339 [TBL] [Abstract][Full Text] [Related]
55. Peroxisomal disorders. A review of a recently recognized group of clinical entities. Talwar D; Swaiman KF Clin Pediatr (Phila); 1987 Oct; 26(10):497-504. PubMed ID: 2443295 [TBL] [Abstract][Full Text] [Related]
56. Neonatal adrenoleukodystrophy. Impaired plasmalogen biosynthesis and peroxisomal beta-oxidation due to a deficiency of catalase-containing particles (peroxisomes) in cultured skin fibroblasts. Wanders RJ; Schutgens RB; Schrakamp G; Tager JM; Van den Bosch H; Moser AB; Moser HW J Neurol Sci; 1987 Feb; 77(2-3):331-40. PubMed ID: 3819771 [TBL] [Abstract][Full Text] [Related]
57. Developmental and pathological expression of peroxisomal enzymes: their relationship of D-bifunctional protein deficiency and Zellweger syndrome. Itoh M; Suzuki Y; Akaboshi S; Zhang Z; Miyabara S; Takashima S Brain Res; 2000 Mar; 858(1):40-7. PubMed ID: 10700594 [TBL] [Abstract][Full Text] [Related]
58. [Clinical biochemical and genetic aspects of peroxisome-deficient disorders]. Suzuki Y No To Hattatsu; 1992 Mar; 24(2):194-7. PubMed ID: 1373633 [TBL] [Abstract][Full Text] [Related]
59. Defective peroxisome biogenesis with a neuromuscular disorder resembling Werdnig-Hoffmann disease. Baumgartner MR; Verhoeven NM; Jakobs C; Roels F; Espeel M; Martinez M; Rabier D; Wanders RJ; Saudubray JM Neurology; 1998 Nov; 51(5):1427-32. PubMed ID: 9818873 [TBL] [Abstract][Full Text] [Related]
60. Low-density particles (W-particles) containing catalase in Zellweger syndrome and normal fibroblasts. Aikawa J; Chen WW; Kelley RI; Tada K; Moser HW; Chen GL Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10084-8. PubMed ID: 1946426 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]